These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 29744254)

  • 81. Clinical Role of Epigenetics and Network Analysis in Eye Diseases: A Translational Science Review.
    Lanza M; Benincasa G; Costa D; Napoli C
    J Ophthalmol; 2019; 2019():2424956. PubMed ID: 31976085
    [TBL] [Abstract][Full Text] [Related]  

  • 82. The miR-503 cluster is coordinately under-expressed in endometrial endometrioid adenocarcinoma and targets many oncogenes, cell cycle genes, DNA repair genes and chemotherapy response genes.
    Devor EJ; Cha E; Warrier A; Miller MD; Gonzalez-Bosquet J; Leslie KK
    Onco Targets Ther; 2018; 11():7205-7211. PubMed ID: 30425513
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Rewiring of miRNA-mRNA bipartite co-expression network as a novel way to understand the prostate cancer related players.
    Naghizadeh MM; Bakhshandeh B; Noorbakhsh F; Yaghmaie M; Masoudi-Nejad A
    Syst Biol Reprod Med; 2023 Aug; 69(4):320-331. PubMed ID: 37018429
    [TBL] [Abstract][Full Text] [Related]  

  • 84. The importance of miRNA-630 in human diseases with an especial focus on cancers.
    Kadkhoda S; Ghafouri-Fard S
    Cancer Cell Int; 2022 Mar; 22(1):105. PubMed ID: 35248081
    [TBL] [Abstract][Full Text] [Related]  

  • 85. miR-15/miR-16 loss, miR-21 upregulation, or deregulation of their target genes predicts poor prognosis in prostate cancer patients.
    Bonci D; De Maria R
    Mol Cell Oncol; 2016 Jul; 3(4):e1109744. PubMed ID: 27652312
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Expression of Concern: miR-130b-3p Modulates Epithelial-Mesenchymal Crosstalk in Lung Fibrosis by Targeting IGF-1.
    PLOS ONE Editors
    PLoS One; 2022; 17(2):e0263701. PubMed ID: 35113960
    [No Abstract]   [Full Text] [Related]  

  • 87. A predictive signature for therapy assignment and risk assessment in prostate cancer.
    Bonci D; De Maria R
    Oncoscience; 2015; 2(11):920-3. PubMed ID: 26697526
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Retraction: MiR-301b promotes the proliferation, mobility, and epithelial-to-mesenchymal transition of bladder cancer cells by targeting
    Biochem Cell Biol; 2023 Aug; 101(4):379. PubMed ID: 36975127
    [No Abstract]   [Full Text] [Related]  

  • 89. MicroRNA-301b and its target gene synaptosome-associated protein 91 as important modulators in esophageal cancer: functional experiments: Retraction.
    Anticancer Drugs; 2022 Apr; 33(4):414. PubMed ID: 35266892
    [No Abstract]   [Full Text] [Related]  

  • 90. Plasmatic MicroRNAs and Treatment Outcomes of Patients with Metastatic Castration-Resistant Prostate Cancer: A Hospital-Based Cohort Study and In Silico Analysis.
    Silva J; Tavares V; Afonso A; Garcia J; Cerqueira F; Medeiros R
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240449
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Development and validation of a genomic nomogram based on a ceRNA network for comprehensive analysis of obstructive sleep apnea.
    Liu W; Sun X; Huang J; Zhang J; Liang Z; Zhu J; Chen T; Zeng Y; Peng M; Li X; Zeng L; Lei W; Cheng J
    Front Genet; 2023; 14():1084552. PubMed ID: 36968605
    [No Abstract]   [Full Text] [Related]  

  • 92. Translational Research for Identifying Potential Early-stage Prostate Cancer Biomarkers.
    Nakamura N; Rogers P; Eggerson R; Post SR; Davis R
    Cancer Genomics Proteomics; 2023; 20(1):1-8. PubMed ID: 36581341
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Prognostic and diagnostic value of circRNA expression in prostate cancer: A systematic review and meta-analysis.
    Xie J; Jiang H; Zhao Y; Jin XR; Li B; Zhu Z; Zhang L; Liu J
    Front Oncol; 2022; 12():945143. PubMed ID: 36419885
    [TBL] [Abstract][Full Text] [Related]  

  • 94.
    Hu N; Wang C; Zhang T; Su H; Liu H; Yang HH; Giffen C; Hu Y; Taylor PR; Goldstein AM
    Cancers (Basel); 2022 Oct; 14(20):. PubMed ID: 36291785
    [TBL] [Abstract][Full Text] [Related]  

  • 95. JSCSNCP-LMA: a method for predicting the association of lncRNA-miRNA.
    Wang B; Wang X; Zheng X; Han Y; Du X
    Sci Rep; 2022 Oct; 12(1):17030. PubMed ID: 36220862
    [TBL] [Abstract][Full Text] [Related]  

  • 96. miR-130b/301b Is a Negative Regulator of Beige Adipogenesis and Energy Metabolism In Vitro and In Vivo.
    Luo W; Kim Y; Jensen ME; Herlea-Pana O; Wang W; Rudolph MC; Friedman JE; Chernausek SD; Jiang S
    Diabetes; 2022 Nov; 71(11):2360-2371. PubMed ID: 36001751
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Hsa-miR-183-5p Modulates Cell Adhesion by Repression of
    Oliveira-Rizzo C; Ottati MC; Fort RS; Chavez S; Trinidad JM; DiPaolo A; Garat B; Sotelo-Silveira JR; Duhagon MA
    Noncoding RNA; 2022 Jan; 8(1):. PubMed ID: 35202085
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Regulation of miRNAs Expression by Mutant p53 Gain of Function in Cancer.
    Madrigal T; Hernández-Monge J; Herrera LA; González-De la Rosa CH; Domínguez-Gómez G; Candelaria M; Luna-Maldonado F; Calderón González KG; Díaz-Chávez J
    Front Cell Dev Biol; 2021; 9():695723. PubMed ID: 34957087
    [TBL] [Abstract][Full Text] [Related]  

  • 99. The role of non-coding RNAs in chemotherapy for gastrointestinal cancers.
    Dashti F; Mirazimi SMA; Rabiei N; Fathazam R; Rabiei N; Piroozmand H; Vosough M; Rahimian N; Hamblin MR; Mirzaei H
    Mol Ther Nucleic Acids; 2021 Dec; 26():892-926. PubMed ID: 34760336
    [TBL] [Abstract][Full Text] [Related]  

  • 100. The Influence of miRNAs on Radiotherapy Treatment in Prostate Cancer - A Systematic Review.
    Soares S; Guerreiro SG; Cruz-Martins N; Faria I; Baylina P; Sales MG; Correa-Duarte MA; Fernandes R
    Front Oncol; 2021; 11():704664. PubMed ID: 34414113
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.